NCT03489889View on ClinicalTrials.gov

Development of Ursodeoxycholic Acid 300 mg at Hospital Das Clinicas of the University of São Paulo School of Medicine

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

June 30, 2018

Conditions
Ursodeoxycholic AcidPrimary Biliary Cirrhosis
Interventions
DRUG

Ursodeoxycholic Acid 300mg tablet

Cross-over study: Ursodeoxycholic Acid 300mg tablet and after Ursodeoxycholic Acid 300mg capsule

DRUG

Ursodeoxycholic Acid 300mg capsule

Cross-over study: Ursodeoxycholic Acid 300mg capsule and after Ursodeoxycholic Acid 300mg tablet

Trial Locations (1)

05403-000

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER

NCT03489889 - Development of Ursodeoxycholic Acid 300 mg at Hospital Das Clinicas of the University of São Paulo School of Medicine | Biotech Hunter | Biotech Hunter